Example: Heart Attack

Clinical Trials Sponsored by Moorfields Eye Hospital NHS Foundation Trust

Total 54 results

  • NCT04557527
    Not yet recruiting
    Suprachoroidal Visco-buckling for the Treatment of Rhegmatogenous Retinal Detachment
    Conditions: Retinal Detachment With Break
  • NCT04639635
    Recruiting
    CNGB1 and Allied Disorders
    Conditions: Retinitis Pigmentosa Associated With CNGB1 Mutations
  • NCT03750201
    Recruiting
    A Study to Assess an Automated Laser Device for Direct Selective Laser Trabeculoplasty
    Conditions: Open Angle Glaucoma, Ocular Hypertension
  • NCT03754153
    Recruiting
    Binocularly Balanced Viewing Study
    Conditions: Amblyopia
  • NCT03531671
    Completed
    Assessing the Optics of the Eye Pre- and Post-operatively in Cataract
    Conditions: Cataract
  • NCT01983488
    Completed
    Clinical Outcome in Uveitis
    Conditions: Uveitis
  • NCT03349801
    Active, not recruiting
    Development of Novel Clinical Endpoints in Intermediate AMD
    Conditions: Age Related Macular Degeneration (AMD)
  • NCT03909425
    Recruiting
    Defining Disease Activity in Neovascular AMD With Optical Coherence Tomography Angiography
    Conditions: Neovascular Age-related Macular Degeneration
  • NCT03893474
    Recruiting
    Quality-Assured Follow-up of Quiescent Neovascular Age -Related maculaR dEgeneration by Non-medical Practitioners
    Conditions: AMD
  • NCT03551574
    Completed
    Adaptive Optics in PVR
    Conditions: Retinal Detachment
  • NCT02828215
    Completed
    Advanced OCT and Adaptive Optics Imaging in Retinal Disease (The ACAD Study)
    Conditions: Vitreous Diseases, Retinal Diseases, Choroidal Diseases
  • NCT01306981
    Completed
    Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot Study
    Conditions: Diabetic Retinopathy, Retinal Neovascularisation
  • NCT01223612
    Completed
    Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation
    Conditions: Diabetic Retinopathy
  • NCT03531047
    Active, not recruiting
    Refractive Corneal Cross-linking for Progressive Keratoconus
    Conditions: Keratoconus
  • NCT04522661
    Not yet recruiting
    A Feasibility Randomised Controlled Trial of Early Vitrectomy for Post-operative Exogenous Endophthalmitis
    Conditions: Endophthalmitis Postoperative Acute
  • NCT03819621
    Completed
    Digital Imaging Assessment of Ocular Prosthesis Motility
    Conditions: Enucleated; Eye
  • NCT02873026
    Recruiting
    Adjunctive Steroid Combination in Ocular Trauma (ASCOT) Study
    Conditions: Eye Injury Trauma
  • NCT03631069
    Active, not recruiting
    Detecting Dementia in the Retina Using Optical Coherence Tomography
    Conditions: Dementia Alzheimers, Dementia, Dementia, Vascular, Dementia Senile
  • NCT02727569
    Completed
    Quantification of Agreement and Variability of a Newly Developed Visual Field Algorithm With the Reference Standard
    Conditions: Glaucoma, Healthy
  • NCT02521311
    Recruiting
    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
    Conditions: Optic Neuritis
  • NCT03102138
    Active, not recruiting
    Retinal Pigment Epithelium Safety Study For Patients In B4711001
    Conditions: Age Related Macular Degeneration
  • NCT01691261
    Active, not recruiting
    A Study Of Implantation Of Retinal Pigment Epithelium In Subjects With Acute Wet Age Related Macular Degeneration
    Conditions: Age Related Macular Degeneration
  • NCT02407678
    Active, not recruiting
    REP1 Gene Replacement Therapy for Choroideremia
    Conditions: Choroideremia
  • NCT01564108
    Completed
    The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema
    Conditions: Uveitis Related Cystoid Macular Edema, Steroid-induced Glaucoma - Borderline
  • NCT02554747
    Completed
    Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa
    Conditions: Diabetic Macular Oedema
Medical Conditions
Sponsors and Collaborators
Drug Interventions
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations